DGKZ expression and VHL mutations in metastatic kidney cancer

Linking DGKZ upregulation to VHL status to identify potential therapeutic targets

INDICATION
Kidney
BIOMARKER
DGKZ

 

Expression of DGKZ among patients with Kidney cancer by VHL mutation status (P/LP only). Wilcoxon rank sum test p-value is depicted. (n=2408).

 

Related cases

Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Abstract pixel art pattern of light purple shapes on a white grid background.

Assessing post-treatment immune profile changes in metastatic kidney cancer

2026-05-26
Kidney
IPS
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
A grid of small orange squares with varying shades forming abstract lines and clusters.

Impact of M2-like macrophage infiltration on RCC immunotherapy outcomes

2026-03-27
Kidney
M2
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Light purple dots forming a stylized bar chart on a white background, showing data patterns.

Investigating LAG-3 expression as a biomarker in mRCC with multimodal data

2026-01-20
Kidney
LAG3